IMMUNOHISTOCHEMISTRY C-MYC Test – DNA Labs UAE
At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY C-MYC test for cancer diagnosis. This test helps detect the presence of the C-MYC protein in tissue samples. Read on to learn more about the test, including its cost, symptoms, diagnosis, and more.
Test Name: IMMUNOHISTOCHEMISTRY C-MYC Test
Components:
- Price: 500.0 AED
Sample Condition:
Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery:
- Sample: Daily by 6 pm
- Report Block: 5 days
- Tissue Biopsy: 5 days
- Tissue large complex: 7 days
Method:
Immunohistochemistry
Test Type:
Cancer
Doctor:
Oncologist, Pathologist
Test Department:
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
Immunohistochemistry (IHC) is a technique used to detect specific proteins in tissues using antibodies. The C-MYC test is an IHC test used to detect the presence of the C-MYC protein in tissue samples. C-MYC is a proto-oncogene that plays a critical role in cell proliferation, differentiation, and apoptosis. It is often overexpressed or amplified in various cancers, including breast, lung, and colorectal cancers.
The C-MYC protein is involved in regulating cell cycle progression and is considered a potential therapeutic target for cancer treatment. The C-MYC test involves staining tissue sections with a specific antibody that recognizes the C-MYC protein. The antibody binds to the C-MYC protein if it is present in the tissue sample. This binding is then visualized using a secondary antibody that is linked to an enzyme or a fluorescent marker. The enzyme or fluorescent marker generates a color or fluorescence signal, respectively, indicating the presence of the C-MYC protein in the tissue.
The C-MYC test can be used to determine the level of C-MYC protein expression in cancer cells, helping to classify tumors and predict patient outcomes. It can also be used to assess the response to targeted therapies that inhibit the C-MYC protein. Overall, the C-MYC test is a valuable tool in cancer research and diagnostics, providing important information about the presence and activity of the C-MYC protein in tissues.
| Test Name | IMMUNOHISTOCHEMISTRY C-MYC Test |
|---|---|
| Components | |
| Price | 500.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details |
Immunohistochemistry (IHC) is a technique used to detect specific proteins in tissues using antibodies. The C-MYC test is an IHC test used to detect the presence of the C-MYC protein in tissue samples. C-MYC is a proto-oncogene that plays a critical role in cell proliferation, differentiation, and apoptosis. It is often overexpressed or amplified in various cancers, including breast, lung, and colorectal cancers. The C-MYC protein is involved in regulating cell cycle progression and is considered a potential therapeutic target for cancer treatment. The C-MYC test involves staining tissue sections with a specific antibody that recognizes the C-MYC protein. The antibody binds to the C-MYC protein if it is present in the tissue sample. This binding is then visualized using a secondary antibody that is linked to an enzyme or a fluorescent marker. The enzyme or fluorescent marker generates a color or fluorescence signal, respectively, indicating the presence of the C-MYC protein in the tissue. The C-MYC test can be used to determine the level of C-MYC protein expression in cancer cells, helping to classify tumors and predict patient outcomes. It can also be used to assess the response to targeted therapies that inhibit the C-MYC protein. Overall, the C-MYC test is a valuable tool in cancer research and diagnostics, providing important information about the presence and activity of the C-MYC protein in tissues. |
